Nervous system diseases and disorders are highly prevalent and substantially contribute to the overall disease burden. Despite significant information provided by the use of animal models in the understanding of the biology of nervous system disorders and the development of therapeutics; limitations have also been identified. Treatment options that are high in efficacy and low in side effects are still lacking for many diseases and, in some cases are nonexistent. A particular problem in drug development is the high rate of attrition in Phase II and III clinical trials. Why do many therapeutics show promise in preclinical animal models but then fail to elicit predicted effects when tested in humans?
On March 28 and 29, 2012, the Institute of Medicine Forum on Neuroscience and Nervous System Disorders convened the workshop “Improving Translation of Animal Models for Nervous System Disorders” to discuss potential opportunities for maximizing the translation of new therapies from animal models to clinical practice. The primary focus of the workshop was to examine mechanisms for increasing the efficiency of translational neuroscience research through discussions about how and when to use animal models most effectively and then best approaches for the interpretation of the data collected. Specifically, the workshop objectives were to: discuss key issues that contribute to poor translation of animal models in nervous system disorders, examine case studies that highlight successes and failures in the development and application of animal models, consider strategies to increase the scientific rigor of preclinical efficacy testing, explore the benefits and challenges to developing standardized animal and behavioral models. Improving the Utility and Translation of Animal Models for Nervous System Disorders: Workshop Summary also identifies methods to facilitate development of corresponding animal and clinical endpoints, indentifies methods that would maximize bidirectional translation between basic and clinical research and determines the next steps that will be critical for improvement of the development and testing of animal models of disorders of the nervous system.

![[PDF] Improving the Utility and Translation of Animal Models for Nervous System Disorders: Workshop Summary Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Institute of Medicine, Diana E. Pankevich, Theresa M. Wizemann, Bruce M. Altevogt](https://digzon.com/wp-content/uploads/2024/04/a074bb773a33aa34ab44f4c89f8d68e0-d.jpg)
![[PDF] Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office Committee on the Review of Priorities in the National Vaccine Plan, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/1f2c64632df721369b594e97e25221d1-d.jpg)
![[PDF] Assessing the Effects of the Gulf of Mexico Oil Spill on Human Health: A Summary of the June 2010 Workshop Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/23a2bd9b1ca80096114a432c7ce891c4-d.jpg)
![[PDF] Preserving Public Trust: Accreditation and Human Research Participant Protection Programs Committee on Assessing the System for Protecting Human Research Subjects, Board on Health Sciences Policy, Institute of Medicine, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/1b86bf2082929593b6cfddb07fb2c1a8-d.jpg)

Reviews
There are no reviews yet.